DK1620423T3 - Fremgangsmåde til fremstillingen af (4-hydroxy-6-oxotetrahydropyran-2-yl) acetonitril og derivater deraf - Google Patents
Fremgangsmåde til fremstillingen af (4-hydroxy-6-oxotetrahydropyran-2-yl) acetonitril og derivater derafInfo
- Publication number
- DK1620423T3 DK1620423T3 DK04730128T DK04730128T DK1620423T3 DK 1620423 T3 DK1620423 T3 DK 1620423T3 DK 04730128 T DK04730128 T DK 04730128T DK 04730128 T DK04730128 T DK 04730128T DK 1620423 T3 DK1620423 T3 DK 1620423T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxy
- preparation
- acetonitrile
- pyran
- tetrahydro
- Prior art date
Links
- NUTZEIABCUGDLR-UHFFFAOYSA-N 2-(4-hydroxy-6-oxooxan-2-yl)acetonitrile Chemical compound OC1CC(CC#N)OC(=O)C1 NUTZEIABCUGDLR-UHFFFAOYSA-N 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101227 | 2003-05-02 | ||
| PCT/NL2004/000284 WO2004096788A1 (en) | 2003-05-02 | 2004-04-28 | Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1620423T3 true DK1620423T3 (da) | 2008-05-26 |
Family
ID=33395971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04730128T DK1620423T3 (da) | 2003-05-02 | 2004-04-28 | Fremgangsmåde til fremstillingen af (4-hydroxy-6-oxotetrahydropyran-2-yl) acetonitril og derivater deraf |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7423162B2 (de) |
| EP (1) | EP1620423B1 (de) |
| JP (1) | JP2006525323A (de) |
| KR (1) | KR20060011984A (de) |
| CN (2) | CN101775000B (de) |
| AT (1) | ATE386734T1 (de) |
| AU (1) | AU2004234308A1 (de) |
| BR (1) | BRPI0409866A (de) |
| CA (1) | CA2524457A1 (de) |
| CO (1) | CO5700715A2 (de) |
| CY (1) | CY1113498T1 (de) |
| DE (1) | DE602004011921T2 (de) |
| DK (1) | DK1620423T3 (de) |
| EA (1) | EA010100B1 (de) |
| ES (1) | ES2300769T3 (de) |
| IL (1) | IL171539A (de) |
| IS (1) | IS8159A (de) |
| NO (1) | NO20055694L (de) |
| NZ (1) | NZ543294A (de) |
| PL (1) | PL1620423T3 (de) |
| SI (1) | SI1620423T1 (de) |
| UA (1) | UA83662C2 (de) |
| WO (1) | WO2004096788A1 (de) |
| ZA (1) | ZA200508862B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2530163C (en) * | 2003-07-25 | 2012-10-02 | Avecia Pharmaceuticals Limited | Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| US7701550B2 (en) | 2004-08-19 | 2010-04-20 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
| DE102005022284A1 (de) | 2005-05-13 | 2006-11-23 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen |
| US8047545B2 (en) * | 2007-11-07 | 2011-11-01 | Douglas Press, Inc. | Lottery-type game with rollover feature |
| WO2009092702A2 (en) * | 2008-01-23 | 2009-07-30 | Lek Pharmaceuticals D.D. | ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof |
| MX2013002674A (es) | 2010-09-09 | 2013-06-13 | Dsm Sinochem Pharm Bv | Sales de esteres de acido 7-amino-3,5-dihidroxiheptanoico. |
| EP2616454B1 (de) * | 2010-09-16 | 2015-04-15 | DSM Sinochem Pharmaceuticals Netherlands B.V. | Hexansäureester als zwischenprodukte zur herstellung von atorvastatin |
| CN105669637A (zh) * | 2014-11-21 | 2016-06-15 | 南京博优康远生物医药科技有限公司 | 一种3,5,6-取代己酸酯衍生物的制备方法 |
| CN112501223B (zh) * | 2020-11-23 | 2022-08-12 | 江苏阿尔法药业股份有限公司 | 制备2-((2r，4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法 |
| CN116102482A (zh) * | 2022-08-17 | 2023-05-12 | 重庆普佑生物医药有限公司 | 一种阿托伐他汀钙的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5097045A (en) * | 1989-02-01 | 1992-03-17 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
| NL1015744C2 (nl) * | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
| WO2004027075A2 (en) * | 2002-09-20 | 2004-04-01 | Diversa Corporation | Chemoenzymatic methods for the synthesis of statins and stain intermediates |
-
2004
- 2004-04-28 BR BRPI0409866-8A patent/BRPI0409866A/pt not_active IP Right Cessation
- 2004-04-28 NZ NZ543294A patent/NZ543294A/en unknown
- 2004-04-28 DE DE602004011921T patent/DE602004011921T2/de not_active Expired - Lifetime
- 2004-04-28 US US10/554,294 patent/US7423162B2/en not_active Expired - Fee Related
- 2004-04-28 AU AU2004234308A patent/AU2004234308A1/en not_active Abandoned
- 2004-04-28 DK DK04730128T patent/DK1620423T3/da active
- 2004-04-28 WO PCT/NL2004/000284 patent/WO2004096788A1/en active IP Right Grant
- 2004-04-28 EA EA200501734A patent/EA010100B1/ru not_active IP Right Cessation
- 2004-04-28 AT AT04730128T patent/ATE386734T1/de active
- 2004-04-28 KR KR1020057020818A patent/KR20060011984A/ko not_active Application Discontinuation
- 2004-04-28 UA UAA200511372A patent/UA83662C2/ru unknown
- 2004-04-28 PL PL04730128T patent/PL1620423T3/pl unknown
- 2004-04-28 CN CN201010111364.9A patent/CN101775000B/zh not_active Expired - Fee Related
- 2004-04-28 SI SI200430673T patent/SI1620423T1/sl unknown
- 2004-04-28 CA CA002524457A patent/CA2524457A1/en not_active Abandoned
- 2004-04-28 ES ES04730128T patent/ES2300769T3/es not_active Expired - Lifetime
- 2004-04-28 EP EP04730128A patent/EP1620423B1/de not_active Expired - Lifetime
- 2004-04-28 JP JP2006507876A patent/JP2006525323A/ja not_active Withdrawn
- 2004-04-28 CN CN2004800117927A patent/CN1780826B/zh not_active Expired - Fee Related
-
2005
- 2005-10-23 IL IL171539A patent/IL171539A/en active IP Right Grant
- 2005-11-01 ZA ZA200508862A patent/ZA200508862B/xx unknown
- 2005-11-02 CO CO05111845A patent/CO5700715A2/es not_active Application Discontinuation
- 2005-11-30 IS IS8159A patent/IS8159A/is unknown
- 2005-12-01 NO NO20055694A patent/NO20055694L/no not_active Application Discontinuation
-
2008
- 2008-05-13 CY CY20081100505T patent/CY1113498T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200501734A1 (ru) | 2006-04-28 |
| IS8159A (is) | 2005-11-30 |
| JP2006525323A (ja) | 2006-11-09 |
| IL171539A (en) | 2011-03-31 |
| ES2300769T3 (es) | 2008-06-16 |
| SI1620423T1 (sl) | 2008-06-30 |
| NO20055694L (no) | 2006-02-02 |
| ZA200508862B (en) | 2007-02-28 |
| CN101775000A (zh) | 2010-07-14 |
| EP1620423B1 (de) | 2008-02-20 |
| EA010100B1 (ru) | 2008-06-30 |
| US7423162B2 (en) | 2008-09-09 |
| CY1113498T1 (el) | 2016-06-22 |
| CA2524457A1 (en) | 2004-11-11 |
| DE602004011921D1 (de) | 2008-04-03 |
| NO20055694D0 (no) | 2005-12-01 |
| CN1780826B (zh) | 2010-05-26 |
| DE602004011921T2 (de) | 2009-02-19 |
| WO2004096788A1 (en) | 2004-11-11 |
| CO5700715A2 (es) | 2006-11-30 |
| ATE386734T1 (de) | 2008-03-15 |
| BRPI0409866A (pt) | 2006-05-16 |
| PL1620423T3 (pl) | 2008-07-31 |
| NZ543294A (en) | 2008-05-30 |
| CN1780826A (zh) | 2006-05-31 |
| KR20060011984A (ko) | 2006-02-06 |
| CN101775000B (zh) | 2014-09-24 |
| UA83662C2 (ru) | 2008-08-11 |
| EP1620423A1 (de) | 2006-02-01 |
| US20060258733A1 (en) | 2006-11-16 |
| AU2004234308A1 (en) | 2004-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055694D0 (no) | Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav | |
| RS51341B (en) | INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole | |
| EA200970569A1 (ru) | Применимые в качестве гербицидных соединений пиридопиразиновые производные | |
| HRP20060073B1 (hr) | Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja | |
| UA81567C2 (en) | Heteroaroyl-substituted phenylalanine amides | |
| EA200600323A1 (ru) | γd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ | |
| CY1106969T1 (el) | Αναστολεις dpp-iv | |
| PL377838A1 (pl) | Zastosowanie pochodnych N-(1-benzylo-2-okso-2-(piperazynylo)etylo)-1-piperydynokarboksyamidowych oraz pokrewnych związków jako antagonistów CGRP do leczenia bólu głowy | |
| ATE461923T1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
| EA200702375A1 (ru) | Производные мочевины, способы их получения и применения | |
| NO20050270L (no) | Nye forbindelser, deres anvendelse og fremstilling | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| SI1831239T1 (sl) | Postopek za pripravo gamma laktona hidroksi beta beta beta beta bismetilen alfa pregn en on karboksilne kisline in ključniintermediati za ta postopek | |
| ES2333026T3 (es) | Derivados de ciclohexil-1,4-diamina sustituidos. | |
| NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
| TW200719889A (en) | Amino acid derivatives | |
| NO20073549L (no) | Fremgangsmate for fremstilling av organiske forbindelser | |
| EA200201101A1 (ru) | Соингибиторы для получения очищенного насыщенного солевого раствора | |
| DK1280812T3 (da) | Cyclipostiner, fremgangsmåde til deres fremstilling og anvendelse af samme | |
| GB0223223D0 (en) | Organic compounds | |
| IS7477A (is) | Aðferð við framleiðslu sýrusalts af gemifloxasíni | |
| NO20064410L (no) | Fremgangsmate for fremstilling av tryptaseinhibitorer | |
| AU2003272083A1 (en) | Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide | |
| HUP0303153A2 (hu) | N-metil-paroxetin és intermedierjei előállítására |